Literature DB >> 15773800

[Stability study of an aqueous formulation of captopril at 1 mg/ml].

M J Escribano García1, S Torrado Durán, J J Torrado Durán.   

Abstract

OBJECTIVE: The stability of captopril was studied in several extemporaneously prepared oral liquid formulations for pediatric use. Solutions were prepared at a concentration of 1 mg/ml from the pure chemical product.
MATERIAL AND METHODS: Captopril 1 mg/ml oral liquid formulations were prepared from powder in three types of water (tap water, mineral water, distilled chemically pure water), in syrup and different chelating and antioxidants agents, and the pH was modified with sodium citrate. The liquids were stored at 4 and 25 degrees C in PVC plastic containers. Samples were removed at regular intervals of less than thirty days. Captopril and captopril disulfide concentrations were analyzed by high-performance liquid chromatography. Captopril in formulations in which the only vehicle was distilled chemically pure water were more stable than in formulations made either with tap water or with mineral water.
RESULTS: The formulations containing edetate disodium, syrup, ascorbic acid, sodium ascorbate, sodium metabisulphite were less stable than those in which the only vehicle was distilled chemically pure water. The change of pH did not improve the formulation stability. The samples stored at 4 degrees C were much more stable than those stored at 25 degrees C, and the microbiological quality was much better.
CONCLUSIONS: Captopril, at a concentration of 1 mg/ml, made with distilled chemically pure water stored in PVC plastic container and protected from light, was stable for 30 days at 4 degrees C.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15773800     DOI: 10.1016/s1130-6343(05)73633-3

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  7 in total

1.  Timing of captopril administration determines radiation protection or radiation sensitization in a murine model of total body irradiation.

Authors:  Thomas A Davis; Michael R Landauer; Steven R Mog; Michal Barshishat-Kupper; Stephen R Zins; Mihret F Amare; Regina M Day
Journal:  Exp Hematol       Date:  2010-01-29       Impact factor: 3.084

2.  Variation in captopril formulations in pharmacies across Canada.

Authors:  Mihir Dipakkumar Bhatt; Jason E Thomas; Tapas Kumar Mondal
Journal:  Paediatr Child Health       Date:  2011-04       Impact factor: 2.253

3.  Effects of captopril against radiation injuries in the Göttingen minipig model of hematopoietic-acute radiation syndrome.

Authors:  W Bradley Rittase; Elizabeth A McCart; Jeannie M Muir; Roxane M Bouten; John E Slaven; Ognoon Mungunsukh; Michelle A Bylicky; W Louis Wilkins; Sang-Ho Lee; Kristbjorn O Gudmundsson; Tiziana Di Pucchio; Cara H Olsen; Yang Du; Regina M Day
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

4.  Deposition of Iron in the Bone Marrow of a Murine Model of Hematopoietic Acute Radiation Syndrome.

Authors:  W Bradley Rittase; Jeannie M Muir; John E Slaven; Roxane M Bouten; Michelle A Bylicky; W Louis Wilkins; Regina M Day
Journal:  Exp Hematol       Date:  2020-03-30       Impact factor: 3.084

5.  Captopril mitigates splenomegaly and myelofibrosis in the Gata1low murine model of myelofibrosis.

Authors:  Seth J Corey; Jyoti Jha; Elizabeth A McCart; William B Rittase; Jeffy George; Joseph J Mattapallil; Hrishikesh Mehta; Mungunsukh Ognoon; Michelle A Bylicky; Thomas A Summers; Regina M Day
Journal:  J Cell Mol Med       Date:  2018-07-04       Impact factor: 5.310

6.  Delayed Captopril Administration Mitigates Hematopoietic Injury in a Murine Model of Total Body Irradiation.

Authors:  Elizabeth A McCart; Young H Lee; Jyoti Jha; Ognoon Mungunsukh; W Bradley Rittase; Thomas A Summers; Jeannie Muir; Regina M Day
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

7.  Iron Deposition and Ferroptosis in the Spleen in a Murine Model of Acute Radiation Syndrome.

Authors:  W Bradley Rittase; John E Slaven; Yuichiro J Suzuki; Jeannie M Muir; Sang-Ho Lee; Milan Rusnak; Grace V Brehm; Dmitry T Bradfield; Aviva J Symes; Regina M Day
Journal:  Int J Mol Sci       Date:  2022-09-20       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.